B
BMRN icon

Barings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Barings’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,104
Closed -$204K – 686
2018
Q3 		$204K Sell
2,104
-1,736
-45% -$173K ﹤0.01% 756
2018
Q2 		$362K Hold
3,840
– – 0.01% 719
2018
Q1 		$311K Hold
3,840
– – ﹤0.01% 802
2017
Q4 		$343K Buy
+3,840
New +$334K ﹤0.01% 803
2017
Q2 		– Sell
-5,222
Closed -$458K – 857
2017
Q1 		$458K Buy
+5,222
New +$465K 0.01% 948
2013
Q4 		– Sell
-3,200
Closed -$231K – 917
2013
Q3 		$231K Buy
+3,200
New +$213K 0.01% 841

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return